GURUFOCUS.COM » STOCK LIST » Consumer Defensive » Consumer Packaged Goods » Biogena Group Invest AG (WBO:BIO) » Definitions » EV-to-EBITDA

Biogena Group Invest AG (WBO:BIO) EV-to-EBITDA : 46.57 (As of May. 29, 2024)


View and export this data going back to 2020. Start your Free Trial

What is Biogena Group Invest AG EV-to-EBITDA?

EV-to-EBITDA is calculated as enterprise value divided by its EBITDA. As of today, Biogena Group Invest AG's enterprise value is €8.20 Mil. Biogena Group Invest AG's EBITDA for the trailing twelve months (TTM) ended in Jan. 2024 was €0.18 Mil. Therefore, Biogena Group Invest AG's EV-to-EBITDA for today is 46.57.

The historical rank and industry rank for Biogena Group Invest AG's EV-to-EBITDA or its related term are showing as below:

WBO:BIO' s EV-to-EBITDA Range Over the Past 10 Years
Min: 8.92   Med: 34.27   Max: 56.77
Current: 46.57

During the past 4 years, the highest EV-to-EBITDA of Biogena Group Invest AG was 56.77. The lowest was 8.92. And the median was 34.27.

WBO:BIO's EV-to-EBITDA is ranked worse than
92.64% of 1549 companies
in the Consumer Packaged Goods industry
Industry Median: 10.63 vs WBO:BIO: 46.57

EV-to-EBITDA is a valuation multiple used in finance and investment to measure the value of a company. This important multiple is often used in conjunction with, or as an alternative to, the PE Ratio to determine the fair market value of a company.

As of today (2024-05-29), Biogena Group Invest AG's stock price is €2.06. Biogena Group Invest AG's Earnings per Share (Diluted) for the trailing twelve months (TTM) ended in Jan. 2024 was €0.043. Therefore, Biogena Group Invest AG's PE Ratio for today is 47.91.

The "classic" EV-to-EBITDA is much better in capturing debt and net cash than the PE Ratio.


Biogena Group Invest AG EV-to-EBITDA Historical Data

The historical data trend for Biogena Group Invest AG's EV-to-EBITDA can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Biogena Group Invest AG EV-to-EBITDA Chart

Biogena Group Invest AG Annual Data
Trend Jan21 Jan22 Jan23 Jan24
EV-to-EBITDA
55.58 14.04 38.76 42.04

Biogena Group Invest AG Semi-Annual Data
Jan21 Jan22 Jan23 Jan24
EV-to-EBITDA - 14.04 38.76 42.04

Competitive Comparison of Biogena Group Invest AG's EV-to-EBITDA

For the Packaged Foods subindustry, Biogena Group Invest AG's EV-to-EBITDA, along with its competitors' market caps and EV-to-EBITDA data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Biogena Group Invest AG's EV-to-EBITDA Distribution in the Consumer Packaged Goods Industry

For the Consumer Packaged Goods industry and Consumer Defensive sector, Biogena Group Invest AG's EV-to-EBITDA distribution charts can be found below:

* The bar in red indicates where Biogena Group Invest AG's EV-to-EBITDA falls into.



Biogena Group Invest AG EV-to-EBITDA Calculation

Biogena Group Invest AG's EV-to-EBITDA for today is calculated as:

EV-to-EBITDA=Enterprise Value (Today)/EBITDA (TTM)
=8.196/0.176
=46.57

Biogena Group Invest AG's current Enterprise Value is €8.20 Mil.
For company reported semi-annually, GuruFocus uses latest annual data as the TTM data. Biogena Group Invest AG's EBITDA for the trailing twelve months (TTM) ended in Jan. 2024 was €0.18 Mil.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


Biogena Group Invest AG  (WBO:BIO) EV-to-EBITDA Explanation

EV-to-EBITDA is a valuation multiple used in finance and investment to measure the value of a company. This important multiple is often used in conjunction with, or as an alternative to, the PE Ratio to determine the fair market value of a company.

Biogena Group Invest AG's PE Ratio for today is calculated as:

PE Ratio=Share Price (Today)/Earnings per Share (Diluted) (TTM)
=2.06/0.043
=47.91

Biogena Group Invest AG's share price for today is €2.06.
For company reported semi-annually, GuruFocus uses latest annual data as the TTM data. Biogena Group Invest AG's Earnings per Share (Diluted) for the trailing twelve months (TTM) ended in Jan. 2024 was €0.043.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Study has found that the companies with the lowest EV-to-EBITDA outperforms companies measured as cheap by other ratios such as PE Ratio.

Please read Which price ratio outperforms the enterprise multiple?


Biogena Group Invest AG EV-to-EBITDA Related Terms

Thank you for viewing the detailed overview of Biogena Group Invest AG's EV-to-EBITDA provided by GuruFocus.com. Please click on the following links to see related term pages.


Biogena Group Invest AG (WBO:BIO) Business Description

Traded in Other Exchanges
N/A
Address
Strubergasse 24, Salzburg, AUT, 5020
Biogena Group Invest AG is a holding company. It is engaged in the development and distribution of products and services in the field of health and nutrition. In particular, the focus is on iron, mineral and osteoporosis product innovations and new integrated solutions in the area of workplace health promotion. Its products include vitamin, mineral, enzymes, medicinal mushrooms, among others.